Metformin

Key Research Papers and Clinical Trials

The current evidence for metformin comes from a limited number of recent studies and ongoing clinical trials. The available research primarily focuses on pregnancy outcomes and combination therapies rather than comprehensive evaluation of metformin's primary diabetes applications.

Recent Research Papers

The research landscape shows very limited recent publications specifically examining metformin. Most of the identified studies from 2026 focus on related metabolic pathways or other diabetes medications (particularly GLP-1 receptor agonists) rather than metformin directly. This includes studies on ischemic optic neuropathy risks with GLP-1 medications and fertility effects of newer diabetes drugs.

One case report examined a rare genetic lipodystrophy syndrome during pregnancy, which may have implications for metformin use in specialized populations, though specific study details and sample sizes are not available from the current evidence.

Clinical Trials

Several clinical trials are investigating metformin, though with varying status and limited detailed information:

Active Studies:

• POEM Study (NCT02947503): A Phase 3 trial currently recruiting participants to evaluate pregnancy outcomes with metformin use
• REMATCH (NCT06627322): A registry-based randomized controlled trial examining metformin in Type 2 diabetes patients with cardiovascular risk factors (currently recruiting)

Other Trials:

• DWP16001 Study (NCT06141980): A Phase 3 long-term safety and efficacy study for a diabetes medication (status unknown)
• Precision Medicine Study (NCT05932251): A diabetes in pregnancy study that has been suspended
• Glimepiride vs. Rimonabant Study (NCT00449605): A terminated Phase 3 trial that was examining combination therapy with metformin

Evidence Limitations

The available evidence is notably thin, with most recent research focusing on newer diabetes medications rather than metformin specifically. The ongoing clinical trials suggest continued interest in metformin's role, particularly in pregnancy and cardiovascular risk management, but completed results are not yet available. Sample sizes and detailed study designs are not provided in the current evidence base.

This synthesis is based solely on the limited evidence provided and does not constitute medical advice. Patients should consult healthcare providers for personalized treatment decisions.